Akebia Therapeutics, Inc. (AKBA)
0.9775
-0.01
(-0.59%)
USD |
NASDAQ |
Sep 04, 16:00
0.9775
0.00 (0.00%)
After-Hours: 17:04
Akebia Therapeutics Cash and Short Term Investments (Annual) : 186.54M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 186.54M |
| December 31, 2024 | 51.87M |
| December 31, 2023 | 42.92M |
| December 31, 2022 | 90.47M |
| December 31, 2021 | 149.80M |
| December 31, 2020 | 269.08M |
| December 31, 2019 | 147.96M |
| December 31, 2018 | 321.64M |
| Date | Value |
|---|---|
| December 31, 2017 | 317.79M |
| December 31, 2016 | 260.34M |
| December 31, 2015 | 138.45M |
| December 31, 2014 | 108.92M |
| December 31, 2013 | 32.56M |
| December 31, 2012 | 1.641M |
| December 31, 2011 | 6.377M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Emergent BioSolutions, Inc. | 209.10M |
| Exelixis, Inc. | 1.059B |
| ADMA Biologics, Inc. | 87.63M |
| Arcutis Biotherapeutics, Inc. | 221.29M |
| Relay Therapeutics, Inc. | 554.52M |